These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms. Fridlender ZG; Sun J; Singhal S; Kapoor V; Cheng G; Suzuki E; Albelda SM Mol Ther; 2010 Nov; 18(11):1947-59. PubMed ID: 20683443 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model. Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212 [TBL] [Abstract][Full Text] [Related]
5. Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma. Kennedy GT; Judy BF; Bhojnagarwala P; Moon EK; Fridlender ZG; Albelda SM; Singhal S Immunol Lett; 2015 Jul; 166(1):28-35. PubMed ID: 25999306 [TBL] [Abstract][Full Text] [Related]
6. Using macrophage activation to augment immunotherapy of established tumours. Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183 [TBL] [Abstract][Full Text] [Related]
7. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model. Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325 [TBL] [Abstract][Full Text] [Related]
8. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy. Kim S; Buchlis G; Fridlender ZG; Sun J; Kapoor V; Cheng G; Haas A; Cheung HK; Zhang X; Corbley M; Kaiser LR; Ling L; Albelda SM Cancer Res; 2008 Dec; 68(24):10247-56. PubMed ID: 19074893 [TBL] [Abstract][Full Text] [Related]
9. Use of protamine to augment adenovirus-mediated cancer gene therapy. Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770 [TBL] [Abstract][Full Text] [Related]
10. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Wildner O; Morris JC Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625 [TBL] [Abstract][Full Text] [Related]
11. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Mizuno M; Ryuke Y; Yoshida J Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy. Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma. Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896 [TBL] [Abstract][Full Text] [Related]
14. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296 [TBL] [Abstract][Full Text] [Related]